Some people receiving Menactra vaccine for meningitis will need to be revaccinated
December 2009
Some people receiving Menactra vaccine for meningitis will need to be revaccinated.
Antibody titers seem to decline over time with Menactra like they do with Menomune.
Experts expected immunity to last longer with Menactra. It's formulated as a conjugate vaccine to elicit a T-cell response and produce prolonged immunity.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote